bioRxiv Science⌕ Search

Biology subjects

CHEN, M.

Publications and source records attributed to CHEN, M..

2 recordsLinked to original sources

Falcons use wind assistance and remote islands to mitigate risk during ocean-crossings

Wind conditions play a major role in determining how birds negotiate ecological barriers during long-distance migration. Migrants typically minimize flights over barriers in opposing winds, while crossing the same barriers directly in supportive winds. Nevertheless, even in supportive conditions, barrier-crossings likely involve a number of risk-mitigating behaviors, including the use of stepping stones. We aimed to understand how seasonal ocean-crossings of Eleonoras falcons (Falco eleonorae) compare in terms of wind support and flight effort, and whether falcons use islands to cross safely in variable wind conditions. To do this we combined GPS-tracking data from 19 individuals over a decade (2012-2022) with wind data from an atmospheric reanalysis model. Despite major differences in wind support, falcons achieved similar ground speeds in both seasons. That is because falcons reduce instantaneous flight effort by flying at lower airspeeds in supportive spring winds (31.5 {+/-} 6.0 km h-1) than in adverse autumn winds (47.4 {+/-} 9.3 km h-1). Overall, it took falcons twice as many flight hours to complete the spring crossings that were 40% greater in terms of air distance compared to autumn crossings. Islands were more frequently used during spring crossings (57.9% individuals in spring vs 21.1% in autumn), and the probability of a falcon using an island significantly increased with weaker wind support in spring (but not in autumn). While wind support partially offsets the extra distance flown over the ocean in spring, isolated islands offer emergency stop-over opportunities when Eleonoras falcons experience relatively weak wind support during protracted ocean crossings.

animal behavior and cognition↗

Glycoengineering of NK cells with glycan ligands of CD22 and selectins for B-cell lymphoma therapy

CD22, a member of Siglec family of sialic acid binding proteins, has restricted expression on B cells. Antibody-based agents targeting CD22 or CD20 (Rituxan) on B lymphoma and leukemia cells exhibit clinical efficacy for treating these malignancies, but also attack normal B cells leading to immune deficiency. Here, we report a chemoenzymatic glycocalyx editing strategy to introduce high-affinity and specific CD22 ligands onto NK-92MI and cytokine-induced killer (CIK) cells to achieve tumor-specific CD22 targeting. These CD22-ligand modified cells exhibited significantly enhanced tumor cell binding and killing in vitro without harming healthy B cells. For effective lymphoma cell killing in vivo we further functionalized CD22 ligand-modified NK-92MI cells with the E-selectin ligand sialyl Lewis X to promote trafficking to bone marrow. The cells containing the ligands of both CD22 and selectins resulted in the efficient suppression of B lymphoma in a xenograft model. Our results suggest that NK cells modified with glycan ligands to CD22 and selectins promote both targeted killing of B lymphoma cells and improved trafficking to sites where the cancer cells reside, respectively.

bioengineering↗